Detalhe da pesquisa
1.
Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries.
BMC Med
; 20(1): 249, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831899
2.
Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register.
Diabetes Obes Metab
; 22(4): 669-679, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903728
3.
Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program.
Lancet Reg Health West Pac
; 32: 100663, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36785858
4.
Cross-sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation Program.
J Diabetes Investig
; 9(6): 1312-1322, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575724
5.
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.
Lancet Diabetes Endocrinol
; 2(12): 935-43, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25081582
6.
Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Filipino cohort of the A1chieve study.
Diabetes Res Clin Pract
; 100 Suppl 1: S35-40, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23647717
7.
Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program.
J Diabetes
; 3(2): 109-18, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21599865